Top Calls on Wall Street: Palantir, CoreWeave, Robinhood, Starbucks and More

Here are Wednesday’s biggest calls on Wall Street:

Morgan Stanley reiterates Starbucks as overweight

Morgan Stanley said it’s sticking with Starbucks following earnings.

“An improving story; debate about earnings power not going away. We are OW rated.”

Bernstein reiterates Robinhood as outperform

Bernstein said it’s sticking with the stock following earnings.

“We still believe, HOOD stock marked the bottom in Q1, already factoring expected weak numbers. April has started strong, with equity, options (highest month YTD)”

Wells Fargo reiterates CoreWeave as overweight

Wells raised its price target to $135 per share from $125.

“While the future state of AI remains uncertain, we believe CRWV is set to benefit in the near term as the leading ‘pick-and-shovel’ infrastructure play, while demand continues to outpace supply.”

Morgan Stanley reiterates Galaxy Digital as overweight

Morgan Stanley said it’s standing by shares of Galaxy following the crypto company’s earnings report.

“Digital Assets performed better than feared, and as crypto markets have seen relief since 3/31, should perform even better in the NT.”

Loop upgrades MaxLinear to buy from hold

Loop said shares of the electronic hardware company have plenty more room to run.

“We missed the pronounced move off the bottom, but our work strongly suggests this train has a lot of room left to run. Furthermore, if MXL actually can achieve what it believes it can then that could be a $1.5B+ revenue driver at > 60% GM.”

Stifel upgrades Crane to buy from hold

Stifel said the stock’s valuation is “attractive.”

“Crane’s Business System-driven operating model drives above-market organic growth and strong incremental margins leading to long-term double-digit organic earnings growth supplemented with mid-single-digit cash earnings growth from further capital deployment over the next several years.”

JPMorgan upgrades Telecom Argentina to overweight from neutral

JPMorgan said the Argentina LatAm company is a consolidation beneficiary.

“We upgrade TEO to OW from N as it seems that the antitrust review of the acquisition of Telefonica Argentina is coming to an end, and we expect TEO to reap substantial benefits from market consolidation in Argentina, where the number of mobile players is being reduced from three to two.”

Loop initiates Legence Corp as buy

Loop said the stock has an “attractive growth story.”

“We are initiating coverage on LGN with a BUY rating and $96 PT since we believe the company is among the most attractive growth stories in our coverage universe for several reasons.”

KeyBanc upgrades Zeta to overweight from sector weight

KeyBanc said it sees “upside optionality” for the software company.

“Zeta could be in the early innings of a multi-pronged inflection toward a more recurring business model benefiting from AI tailwinds.”

Evercore ISI upgrades Armstrong World to outperform from in line

Evercore said investors should buy the dip in the building products company following earnings.

“Armstrong World Industries (AWI) reported 1Q26 adjusted EPS of $1.69 vs. our $1.77 and consensus’ $1.81 estimate.”

Baird upgrades Qiagen to outperform from neutral

Baird upgraded the molecular diagnostics company following earnings.

“Upgrading QGEN to Outperform, new $43 price target (-$10) implies ~25-30% upside using relatively conservative assumptions and ~16.5X 2027 P/E.”

Oppenheimer upgrades T-Mobile US to outperform from perform

KeyBanc upgraded the stock following earnings.

“TMUS reported an in-line quarter and modestly raised guidance, but company positioned to use AI to raise prices, slash expenses, and grow new services. Management is no longer disclosing volume metrics which is another sign that it will focus on ARPA growth, instead of postpaid phone adds

Read more.

Evercore ISI initiates Standard Lithium as outperform

Evercore said the lithium company is well positioned.

“Standard Lithium leads the pack in demonstrating and perfecting process expertise in DLE (direct lithium extraction) with project development in prime Smackover resource, among North America’s highest lithium-in-brine concentrations.”

BTIG initiates Hyperfine as buy

BTIG said the medical imaging company is firing on all cylinders.

“Hyperfine is the developer of the Swoop System, an ultra-low field portable MRI system commercially available in the U.S. The Swoop System enables point-of-care brain MRI at the bedside, expanding access to MRI imaging by eliminating the need for a shielded room, specialized staff, and patient transport.”

Bank of America upgrades Victoria’s Secret to buy from neutral

Bank of America said it sees a robust earnings growth outlook.

“We are upgrading the stock to Buy from Neutral as we think VSCO’s sales momentum will continue, supporting mid to high-teens EPS growth driven by operating margin expansion from the current 6%.”

Bank of America upgrades Radian Group to buy from neutral

Bank of America said the global insurer is “cheap.”

“We upgrade Radian (RDN) to Buy from Underperform and raise our PO to $43 from $35.”

Bank of America upgrades Elevance Health to buy from underperform and Molina and Centene to buy from underperform

Bank of America upgraded several healthcare companies on Wednesday and says the stocks are at a “trough.”

“We are upgrading ELV and double upgrading CNC and MOH to Buy on a view that Medicaid margins are likely bottoming in 2026 and the return to target margins are more a matter of time and math, as state data slowly catches up to trend/risk pool shifts in 2024/25, improving rates and margins in 2027+.”

Baird reiterates Palantir as outperform

The firm said it’s bullish ahead of the Palantir’s earnings report and that it’s a top idea.

“Looking ahead, we believe 2026/2027 numbers continue to move higher (we’re anchoring to $7.5 billion of FCF in 2027 as a reasonable upside case, vs. our current $5.76 billion estimate), and think the stock’s recent digestion period presents a good opportunity to purchase a premier growth asset that continues to grow into its valuation.”

Rosenblatt upgrades Spotify to buy from neutral

Rosenblatt upgraded the stock following earnings.

“Spotify’s 1Q26 was in-line better than estimated. The 2Q26 guide was fine on sales, but low for operating income and a slight miss on premium subscribers.”